Literature DB >> 33584095

Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study.

Rana M Gebreel1, Noha A Edris2, Hala M Elmofty2, Mina I Tadros3,4, Mohamed A El-Nabarawi3, Doaa H Hassan1.   

Abstract

AIM: Norfloxacin (NFX) has low ocular bioavailability. The current work aimed to develop NFX-loaded nanoparticle (NP)-laden hydrogels to improve the ocular potential of NFX, minimize the need for frequent instillations and lower undesirable side effects.
METHODS: NFX-loaded NPs were developed via the double-emulsion/solvent evaporation technique, according to 21.41 full factorial design, using two types of polylactic-co-glycolic acid (PLGA) polymer and four (drug: polymer) ratios. NPs were evaluated for particle size (PS), polydispersity index (PDI), zeta potential (ZP), drug entrapment efficiency percentage (EE%), drug percentage released after 30 min (Q30min) and 12 hours (Q12h), drug percentage permeated through goat corneas after 30 min (P30min) and 12 hours (P12h) and morphology. Two formulae were statistically selected and incorporated into hydroxypropyl methylcellulose (HPMC)-based hydrogels; G1 - G4. The latter systems were evaluated for appearance, clarity, pH, spreadability, rheology, drug percentages released, drug percentages permeated, antimicrobial activity against Pseudomonas aeruginosa, and histopathological changes.
RESULTS: The selected NPs (NP2 and NP6) were spherical in shape and possessed suitable PS (392.02 nm and 190.51 nm) and PDI (0.17 and 0.18), high magnitude of ZP (-30.43 mV and -33.62 mV), high EE% (79.24% and 91.72%), low Q30min (10.96% and 16.65%) and P30min (17.39% and 21.05%) and promising Q12h (58.23% and 71.20%) and P12h (53.31% and 65.01%), respectively. Clear, spreadable, tolerable, pseudoplastic, and thixotropic HPMC-based hydrogels were developed. They showed more prolonged drug release and drug permeation profiles. NP2- and NP6-laden hydrogels (G3 and G4 systems, respectively) had promising antibacterial activity, and reasonable histopathological safety.
CONCLUSION: G3 and G4 are potential ocular delivery systems for NFX.
© 2021 Gebreel et al.

Entities:  

Keywords:  PLGA; Pseudomonas keratitis; nanoparticles; norfloxacin; ocular delivery

Mesh:

Substances:

Year:  2021        PMID: 33584095      PMCID: PMC7875077          DOI: 10.2147/DDDT.S293127

Source DB:  PubMed          Journal:  Drug Des Devel Ther        ISSN: 1177-8881            Impact factor:   4.162


  60 in total

Review 1.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

Review 2.  Development of nanoparticles for antimicrobial drug delivery.

Authors:  L Zhang; D Pornpattananangku; C-M J Hu; C-M Huang
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  Advances and limitations of drug delivery systems formulated as eye drops.

Authors:  Clotilde Jumelle; Shima Gholizadeh; Nasim Annabi; Reza Dana
Journal:  J Control Release       Date:  2020-02-03       Impact factor: 9.776

4.  Direct detection of saponins in crude extracts of soapnuts by FTIR.

Authors:  Meshari Saad Almutairi; Muhammad Ali
Journal:  Nat Prod Res       Date:  2014-12-24       Impact factor: 2.861

5.  Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.

Authors:  Yusuf Onlen; Cengaver Tamer; Hüseyin Oksuz; Nizami Duran; Mehmet Enes Altug; Selvinaz Yakan
Journal:  Microbiol Res       Date:  2006-08-10       Impact factor: 5.415

6.  Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests.

Authors:  S M Soliman; N S Abdel Malak; O N El-Gazayerly; A A Abdel Rehim
Journal:  Drug Discov Ther       Date:  2010-12

7.  Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.

Authors:  Haiou Wang; Yuntao Jia; Wenjing Hu; Huiming Jiang; Jingqing Zhang; Liangke Zhang
Journal:  Pharm Dev Technol       Date:  2012-06-07       Impact factor: 3.133

8.  Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

Authors:  Marios Constantinou; Mark Daniell; Grant R Snibson; Hien T Vu; Hugh R Taylor
Journal:  Ophthalmology       Date:  2007-09       Impact factor: 12.079

9.  Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.

Authors:  Saadia Ahmed Tayel; Mohamed Ahmed El-Nabarawi; Mina Ibrahim Tadros; Wessam Hamdy Abd-Elsalam
Journal:  Int J Pharm       Date:  2013-01-16       Impact factor: 5.875

Review 10.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.

Authors:  Raghavendra C Mundargi; V Ramesh Babu; Vidhya Rangaswamy; Pradip Patel; Tejraj M Aminabhavi
Journal:  J Control Release       Date:  2007-10-22       Impact factor: 9.776

View more
  4 in total

1.  Topical tacrolimus nanocapsules eye drops for therapeutic effect enhancement in both anterior and posterior ocular inflammation models.

Authors:  Leslie Rebibo; Connie Tam; Yan Sun; Eve Shoshani; Amit Badihi; Taher Nassar; Simon Benita
Journal:  J Control Release       Date:  2021-03-30       Impact factor: 9.776

2.  Development of topical chitosan/ β-glycerophosphate-based hydrogel loaded with levofloxacin in the treatment of keratitis: An ex-vivo study.

Authors:  Yu-Fan Chang; Yung-Hsin Cheng; Yu-Chieh Ko; Shih-Hwa Chiou; Catherine Jui-Ling Liu
Journal:  Heliyon       Date:  2021-12-30

3.  Degradable and Non-Degradable Chondroitin Sulfate Particles with the Controlled Antibiotic Release for Bacterial Infections.

Authors:  Selin S Suner; Mehtap Sahiner; Ramesh S Ayyala; Nurettin Sahiner
Journal:  Pharmaceutics       Date:  2022-08-20       Impact factor: 6.525

4.  Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment.

Authors:  Miriam Ana González-Cela-Casamayor; José Javier López-Cano; Irene Bravo-Osuna; Vanessa Andrés-Guerrero; Marta Vicario-de-la-Torre; Manuel Guzmán-Navarro; José Manuel Benítez-Del-Castillo; Rocío Herrero-Vanrell; Irene Teresa Molina-Martínez
Journal:  Pharmaceutics       Date:  2022-07-04       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.